ScirosBio

ScirosBio is a biopharmaceutical platform start-up based in Abu Dhabi, UAE. The company focuses on the research, development, and commercialization of innovative drugs targeting various therapeutic areas, including oncology, neurological disorders, and diabetes. Utilizing its RAID Technology Platform, ScirosBio combines reactive oxygen species modulating small molecules with established therapeutics to improve treatment outcomes. This approach allows for rapid clinical development and leverages well-understood active substances with proven safety profiles. The company is dedicated to drug discovery, clinical advancement, and the commercialization of pharmaceutical products.